Skip to main content
. 2023 Aug 25;29(9):2216–2223. doi: 10.1038/s41591-023-02494-2

Fig. 1. CONSORT diagrams.

Fig. 1

a,b, Participant allocation for the SAD and MAD HP cohorts (a) and dyslipidemic cohorts (b) in the phase 1 AROANG1001 study. Note: The key results from this study are first reported for HPs and individuals with hepatic steatosis.